Intrinsyc Technologies (TSX: ITC and OTC: ISYRF) debuts system on module and development kit powered by NXP i.MX 8M processor
Powerful Embedded Computing Solutions Optimized for Multimedia Applications
VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) ("Intrinsyc" or the "Company"), a leading provider of solutions for the development and production of embedded and Internet of Things ("IoT") products, today announced the availability of the Open-X(TM) 8M System on Module ("SOM") and Development Kit.
Intrinsyc's Open-X(TM) 8M SOM incorporates the new 64-bit NXP i.MX 8M processor and is ideal for powering IoT devices ranging from consumer smart home appliances to industrial building automation products. Its ultra-compact (55mm x 35mm) size enables its use in a wide range of form factors. The feature-rich SOM, with its advanced video and audio features, is ideal for streaming video/audio devices, voice control applications, and human-machine interface solutions. It offers high quality video playback with full 4K UHD and HDR along with the highest level of pro-audio fidelity. The broad range of interfaces, including HDMI 2.0a, two USB 3.0, one PCIe, Gigabit Ethernet, and pre-certified dual-band 2x2 MU-MIMO WLAN make the SOM suitable for a wide range of embedded and IoT products.
"We are excited to expand our portfolio of embedded SOM solutions with the newly launched NXP i.MX 8M processor," stated Cliff Morton, Vice President, Client Solutions, Intrinsyc Technologies Corporation. "Intrinsyc's Open-X(TM) SOMs provide a flexible way to rapidly bring IoT devices to market with reduced risk; combining the time-to-market benefits of an off-the-shelf product, with the flexibility and optimization of a custom design. Our latest System on Module, the Open-X(TM) 8M, is ready for production use and will expand opportunities in a variety of multimedia capable embedded and IoT products."
"Intrinsyc has a long history of providing exceptional product development services for embedded and IoT devices," stated Robert Thompson, i.MX Ecosystem Manager at NXP Semiconductors, N.V. "We are pleased to see the launch of Intrinsyc's production-ready SOM and development kit powered by the i.MX 8M processor. Intrinsyc's strong product development and technical support capabilities, coupled with a production-ready i.MX 8M powered SOM will help companies rapidly develop their multimedia capable products."
Open-X(TM) 8M SOM Specifications
- Quad-core ARM Cortex-A53 MPCore platform
- Quad symmetric Cortex-A53 processors: 32 KB L1 Instruction Cache, 32 KB L1 Data Cache
- Support of 64-bit ARMv8-A architecture: 1 MB unified L2 cache, Frequency of 1.5 GHz
- ARM Cortex-M4 core platform
- 16 KB L1 Instruction Cache, 16 KB L1 Data Cache, 256 KB tightly coupled memory (TCM)
- 3GB LPDDR4 RAM, 16GB eMMC Flash
Wireless Module - FCC/IC pre-certified
- WLAN 802.11a/b/g/n/ac 2.4/5.0 GHz 2x2 MU-MIMO
- Bluetooth 4.1
- HDMI 2.0a supporting resolution up to 4096 x 2160 at 60 Hz
- 4-lane MIPI DSI supporting display resolution up to 1920x1080 at 60 Hz
- 2x 4-lane MIPI CSI2 camera inputs
- 4Kp60 HEVC/H.265 main, and main 10 decoder
- 4Kp60 VP9 decoder
- 4Kp30 AVC/H.264 decoder
- 1080p60 MPEG-2, MPEG-4p2, VC-1, VP8, RV9, AVS, MJPEG, H.263 decoder
- 4 shader
- 267 million triangles/sec
- 1.6 Giga pixel/sec
- 32 GFLOPs 32-bit or 64 GFLOPs 16-bit
- Supports OpenGL ES 1.1, 2.0, 3.0, 3.1, Open CL 1.2, and Vulkan
- S/PDIF input and output
- 1x 16 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)
- 1x 8 channel receive SAI digital audio interface (I2S, AC97, TDM, DSP)
- 2x 2 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)
- 2x USB 3.0, 1x PCIe Gen2, Gigabit Ethernet, 4-bit SDIO, 2x debug UART, JTAG
- Linux & Android 8
- Input power: 3.3V
- Operating Temperature: 0°C to +70°C
Additional information is available at: https://www.intrinsyc.com/imx-embedded-development-kits/open-x-8m-development-kit/
To enable rapid development of devices using the Open-X(TM) 8M SOM, Intrinsyc offers the Open-X(TM) 8M Development Kit; a full-featured development platform including the software tools and accessories required to immediately begin development.
Intrinsyc's Open-X(TM) 8M Development Kit is a cost-effective, feature rich, multimedia-focused, exposed board platform powered by our Open-X(TM) 8M System on Module (SOM). It is ideal for evaluation of the Open-X(TM) 8M SOM as well as jump-starting development of streaming video/audio devices, voice control and general human-machine interface solutions. HDMI 2.0a video output is provided for ease of use out of the box, and our optional LCD/touchpanel is also compatible. With a multitude of high performance interconnect options, including two USB3.0 ports, Gigabit Ethernet, PCIe Gen2, and pre-certified dual-band 2x2 MU-MIMO WLAN, this platform is ideal for development of a wide range of multimedia capable embedded and IoT applications.
In support of new product designs based on the Open-X(TM) 8M SOM, Intrinsyc offers a robust board support package, advanced technical support and comprehensive product development services including; rapid prototyping, mechanical and electrical design, BSP and driver development, and middleware and application development. Contact Intrinsyc at sales@Intrinsyc.com with your product requirements and have one of the Company's solution architects help plan for your successful product development and launch.
Intrinsyc will showcase the Open-X(TM) 8M SOM and Development Kit at Embedded World 2018, Nuremberg Exhibition Centre Booth 4A-425, Nuremberg, Germany, from 27 February to 1 March.
About Intrinsyc Technologies Corporation
Intrinsyc Technologies Corporation is a product development company that provides hardware, software, and engineering and production services that enable rapid commercialization of embedded and Internet of Things (IoT) products. Solutions span the development life cycle from concept to production and help device makers and technology suppliers create compelling differentiated products with faster time-to-market. Intrinsyc's Open-Q(TM) and Open-X(TM) System on Modules incorporate the industry's most advanced processor technology and help OEMs to rapidly bring industry leading products, with rich functionality and high performance, to market. Intrinsyc is publicly traded (TSX:ITC) (OTC:ISYRF) and is headquartered in Vancouver, BC, Canada.
For more information, please contact:
Senior Marketing Communications Coordinator
Intrinsyc Technologies Corporation
Intrinsyc, Open-X and their respective logos are trademarks, registered and otherwise, of Intrinsyc Technologies Corporation in Canada, European Union, Taiwan, United States of America and other jurisdictions
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Intrinsyc Technologies Corporation via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 1017.12.2018 17:52 | Pressemelding
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced the publication of a peer-reviewed manuscript describing the previously announced interim results of a clinical trial of QR-110 for the treatment of Leber’s congenital amaurosis 10 (LCA10) in the journal Nature Medicine. “It was enormously gratifying to see robust improvements in visual acuity and significant augmentations in the patient’s ability to detect lights, and impressive to observe these effects within the first three months following a single injection,” said Professor Artur V. Cideciyan, Ph.D., who was one of the co-investigators at the Scheie Eye Institute of the University of Pennsylvania. “LCA10 is a severe form of childhood blindness and this is a major step forward in the treatment of these previously
Allied Esports™ Announces Formation of World’s First Affiliate Program for Esports Venues17.12.2018 15:30 | Pressemelding
Allied Esports™ Property Network to Offer Members Access to Global Events and Content, Expertise in Design and Operations, and Unique Sponsorship OpportunitiesFortress Esports Joins Program with Partnership Covering Exclusive Rights to New Properties in Australia and New Zealand ORANGE COUNTY, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Allied Esports™, a global esports entertainment company, today announced the formation of the world’s first esports venue affiliate program – the Allied Esports Property Network – created for global partners interested in participating in Allied Esports’ global event programming, and licensing Allied Esports’ design, development and operations expertise for their own dedicated esports venues. The Allied Esports Property Network will provide members with access to Allied Esports’ global platform of events and content production, providing participants and viewers with integrated experiences both in-person and online. Affiliate members will be fully incorpo
Aryaka Names Cloud and Software Industry Veteran, Deepak Kumar, as Senior Vice President of Customer Success17.12.2018 15:00 | Pressemelding
SAN MATEO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading SD-WAN as a Service provider, announced today that Deepak Kumar, a 20-year cloud and enterprise software industry veteran, has joined the company’s leadership team as Senior Vice President, Customer Success. "We’re thrilled to welcome Deepak to Aryaka; his leadership will help us further enhance our end-user customer experience worldwide,” said Matt Carter, CEO of Aryaka. “His expertise in building and nurturing enterprise relationships will be critical as we continue to grow in 2019 and beyond.” Before joining Aryaka, Kumar was the SVP & GM at 7.ai, a Sequoia portfolio company in the customer experience domain. As SVP Business Development, he was responsible for building out strategic partnerships and alliances. His hard work grew the channel driven revenue significantly. As General Manager, Kumar was responsible for the Customer Acquisition Cloud product line. The product line was built based on strategic a
Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow17.12.2018 14:00 | Pressemelding
Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization via an amendment to its existing license from Health Canada under the Cannabis Act. This authorization will allow Highland Grow to sell cannabis products to end consumers through appropriate medical and recreational cannabis channels, dramatically increasing product availability. The sales authorization will position Biome Grow to serve the rapidly growing domestic and international cannabis markets. "Biome Grow has been steadfast in its focus on a regional business strategy and building provincial brands that can serve the unique requirements of its local cannabis consumers. This n
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis17.12.2018 13:30 | Pressemelding
DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis (MS). Alkermes is seeking approval of diroximel fumarate under the 505(b)(2) regulatory pathway, and the NDA submission includes data from EVOLVE-1, a Phase 3 pivotal trial that evaluated long-term safety in relapsing-remitting MS (RRMS) with approximately 700 patients dosed with diroximel fumarate. If approved, Biogen intends to market diroximel fumarate under the brand name VUMERITY™. This name has been conditionally accepted by the FDA and will be confirmed upon approval. “Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated
SoftServe Documentary Receives “The Best Corporate Media of Ukraine 2018” Award17.12.2018 13:00 | Pressemelding
25th anniversary documentary takes prize in “The Best Corporate Movie” category AUSTIN, Texas, Dec. 17, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces the Ukrainian Association of Corporate Media, a public organization uniting professionals in the field of marketing, PR, journalism, and advertising, recognized SoftServe in its annual competition – “The Best Corporate Media of Ukraine 2018.” SoftServe’s 25th anniversary documentary took second place in the “The Best Corporate Movie Category.” The documentary honors the company’s 25th anniversary with an inside look at how SoftServe evolved over the past quarter century to become a leading digital authority. In the documentary, SoftServe’s founders and leadership share their inspiring stories and highlight the company’s achievements over the years. “It is a great honor to receive this recognition from the Ukrainian Association of Corporate Media for our 25th anniversary documentary,” sai